EUVIMEDEUVIMED entdecken
Fallbericht

Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report

Katie Yusun Kwon, Facundo Iriarte, Heather Ann Hartman, Juhi Mittal, Antonio Di Carlo, Abbas El-Sayed Abbas

Gastrointestinal Stromal Tumor · 2022

DOI: 10.21037/gist-21-12 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Gastrointestinal Stromal Tumor, 2022. Verfasst von Katie Yusun Kwon und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrointestinal stromal tumors (GISTs) can arise anywhere in the gastrointestinal tract, but predominately originate from the stomach. They are most commonly due to mutations in tyrosine kinase KIT or PDGFRA. While imatinib can be used as treatment for GISTs, the leading curative option is surgical resection, especially in the setting of primary resistance. In this case report, we describe an unusual history of a patient with a gastric GIST undergoing neoadjuvant imatinib therapy during 2020. Due to restrictions imposed by the pandemic, this patient had difficulty with in-person follow-up. After 2 months of imatinib therapy, the patient was contacted by voice-only telemedicine and reported massive abdominal distention and dyspnea. He was brought in urgently to the hospital. On exam and by computed tomography (CT) scan, the tumor appeared to have almost doubled in size, making it the largest GIST by volume reported in medical literature to date. The patient underwent an urgent laparotomy for complete resection of the tumor. Despite the exponential growth of the tumor, it remained attached only to the gastric body by a small stalk without invasion of neighboring structures. He was discharged without complications and has had no signs of recurrence at 6 months. This case reports highlights the importance of monitoring massive GIST tumors, despite imatinib therapy in the setting of the COVID-19 pandemic restrictions.

Zitieren

APA

Kwon, K. Y., Iriarte, F., Hartman, H. A., Mittal, J., Carlo, A. D., & Abbas, A. E. (2022). Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report. Gastrointestinal Stromal Tumor. https://doi.org/10.21037/gist-21-12

Vancouver

Kwon KY, Iriarte F, Hartman HA, Mittal J, Carlo AD, Abbas AE. Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report. Gastrointestinal Stromal Tumor. 2022. doi:10.21037/gist-21-12

BibTeX
@article{Kwon2022,
  author = {Kwon, Katie Yusun and Iriarte, Facundo and Hartman, Heather Ann and Mittal, Juhi and Carlo, Antonio Di and Abbas, Abbas El-Sayed},
  title = {Resection of a giant gastrointestinal stromal tumor after failed imatinib treatment during the COVID-19 pandemic: a case report},
  journal = {Gastrointestinal Stromal Tumor},
  year = {2022},
  doi = {10.21037/gist-21-12}
}
Kostenlos starten →